Latest Breaking News On - Reneo pharmaceuticals inc - Page 5 : comparemela.com

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Danielle spanglerReneo pharmaceuticalsExchange commissionReneo pharmaceuticals incThree months ended marchPrivate securities litigation reform actMonths ended march

Reneo Pharmaceuticals (NASDAQ:RPHM) Stock Price Up 0 6%

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report)’s stock price traded up 0.6% on Tuesday . The company traded as high as $1.71 and last traded at $1.71. 86,279 shares were traded during trading, a decline of 73% from the average session volume of 318,690 shares. The stock had previously closed at $1.70. Analyst Upgrades […]

United statesPiper sandlerGoldman sachs group incCapital managementHedge funds weigh in on reneo pharmaceuticalsReneo pharmaceuticals incJefferies financial groupReneo pharmaceuticals stockReneo pharmaceuticalsCapital partnersReneo pharmaceuticals company profileNews ratings for reneo pharmaceuticals dailyGet free reportSachs groupFire capitalVestal point capital

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic

Danielle spanglerExchange commissionReneo pharmaceuticals incReneo pharmaceuticalsFourth quarterFull yearPrivate securities litigation reform actEnded decemberNation world

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the.

Danielle spanglerExchange commissionReneo pharmaceuticalsReneo pharmaceuticals incFourth quarterFull yearPrivate securities litigation reform actEnded december

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

IRVINE, Calif., March 28, 2024 Reneo Pharmaceuticals, Inc. , a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic.

Danielle spanglerExchange commissionReneo pharmaceuticalsReneo pharmaceuticals incFourth quarterFull yearPrivate securities litigation reform actEnded december